Nonalcoholic fatty liver disease (NAFLD) is a common, progressive liver disease that affects
up to one-quarter of the adult population worldwide. The clinical and economic burden of …

Cardiovascular diseases (CVDs) remain a leading cause of death worldwide. Among the
major risk factors for CVD, obesity and diabetes mellitus have received considerable …

Heart failure (HF) and nonalcoholic fatty liver disease (NAFLD) are 2 conditions that have
become important global public health problems. Emerging evidence supports a strong and …

Nonalcoholic fatty liver disease (NAFLD) is common in the elderly, in whom it carries a more
substantial burden of hepatic (nonalcoholic steatohepatitis, cirrhosis and hepatocellular …

Cardiac arrhythmias and the resulting sudden cardiac death are significant cardiovascular
complications that continue to impose a heavy burden on patients and society. An emerging …

Non-alcoholic fatty liver disease (NAFLD) has emerged as a public health problem of
epidemic proportions worldwide. Accumulating clinical and epidemiological evidence …

Non-alcoholic fatty liver disease (NAFLD) is an increasingly prevalent disease globally.
Current estimates are that 24% of the adult population, thus, one billion individuals …

Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease.
NAFLD includes a wide spectrum of liver conditions ranging from simple steatosis to …

Non-alcoholic fatty liver disease (NAFLD) and atrial fibrillation (AF) are widespread diseases
and have multiple common risk factors and comorbidities. No studies of association between …

Background & Aims Approximately 50% of hypertensive patients have non-alcoholic fatty
liver disease (NAFLD), but whether change in fatty liver status over time modifies risk of …